Half of Patients With MS Do Not Take Disease-Modifying Medication Within Four Years of DiagnosisFebruary 1, 2012Multiple Sclerosis
Gray Matter Atrophy May Serve as an Effective Outcome Measure for MS Clinical TrialsFebruary 1, 2012Multiple Sclerosis
Use of Revised MS Diagnostic Criteria May Allow Earlier Diagnosis in Pediatric PatientsJanuary 1, 2012Multiple Sclerosis
International Consortium to Study Factors That Predict Disease Progression in MSJanuary 1, 2012Multiple Sclerosis
Literature MonitorJanuary 1, 2012Alzheimer's & CognitionMultiple SclerosisMovement DisordersParkinson's Disease
Clinical Trial Results and Other Research News From ECTRIMS/ACTRIMSNovember 1, 2011Multiple Sclerosis
Corpus Callosum Atrophy May Be an Effective MRI Marker for Long-Term Disease Progression in MSNovember 1, 2011Multiple Sclerosis
Vitamin D May Not Be Linked to Cognition, Psychological Symptoms in MSOctober 1, 2011Multiple Sclerosis
